FluidForm Bio
PrivateLast Round
Seed
Jul 16, 2026
Total Funding Raised
$733,563
Momentum
Top 25%
of companies Caplight tracks
Company Overview
FluidForm Bio operates in Healthcare & Life Sciences and is based in Waltham, Massachusetts. Its latest recorded funding round was a Strategic round in January 2022.
FluidForm Bio is a biotechnology company that develops life-extending tissue therapeutics and 3D bioprinting solutions using its patented FRESH™ technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, 3D Printing, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FluidForm Bio Comparables
Compare FluidForm Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Poietis | 85% | |
| Black Drop Biodrucker GmbH | 82% | |
| Aspect Biosystems | 82% |
For institutional investors. Book with your work email.
FluidForm Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 16, 2026 | ||||
| Convertible Debt | Apr 16, 2025 | ||||
| Strategic | Jan 11, 2022 | ||||
| Grant | May 1, 2021 | ||||
| Grant | Apr 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
FluidForm Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| StartEngine Crowdfunding | Convertible Debt |
| Hackensack Meridian Health | Strategic |
| National Heart, Lung, and Blood Institute | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 58% MoM.
- Jul 20, 2026
Open roles increased from 0 to 5, representing 31% of headcount.
For institutional investors. Book with your work email.
FluidForm Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about FluidForm Bio's valuation, stock price, and market status.
Is FluidForm Bio a public or private company?
FluidForm Bio is a private company.
What is the current stock price of FluidForm Bio?
FluidForm Bio is a private company, so its shares have no public market price. Caplight tracks FluidForm Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is FluidForm Bio worth (valuation)?
Valuation information for FluidForm Bio is not publicly available.
Can I buy FluidForm Bio stock?
FluidForm Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was FluidForm Bio's last funding round?
FluidForm Bio's most recent funding round was Seed on July 16, 2026.
Who are the main investors in FluidForm Bio?
Key investors in FluidForm Bio include Hackensack Meridian Health.
Will FluidForm Bio IPO soon?
No public IPO plans have been announced for FluidForm Bio.
How can I track FluidForm Bio secondary market activity?
Caplight tracks bids, offers, and trades in FluidForm Bio's shares on secondary markets.